Author:
Niyazi Maximilian,Marini Patrizia,Daniel Peter T.,Humphreys Robin,Jendrossek Verena,Belka Claus
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology, Nuclear Medicine and imaging
Reference49 articles.
1. Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999;104:155–62.
2. Attard G, Plummer R, de Bono JS, et al. Phase I and pharmacokinetic study of HGS-ETR2, a fully human agonistic monoclonal antibody to TRAIL-R2, in patients with advanced solid malignancies. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Philadelphia, 14–18 November 2005.
3. Baierlein SA, Distel L, Sieber R, et al. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells. Strahlenther Onkol 2006;182:467–72.
4. Baumann M, Krause M, Dikomey E, et al. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms. Radiother Oncol 2007;83:238–48.
5. Belka C, Betsch A, Marini P, et al. Death inducing ligands in combination with ionizing radiation: objective and current knowledge. Strahlenther Onkol 2003;179:141–51.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献